Evidence map›Paper›PMID 40933047›Full record

ArticleFrontiers in neurology2025

Endovascular management of carotid-cavernous fistulas: a 16-year retrospective analysis of multimodal treatment strategies and long-term clinical outcomes.

Chingiz Nurimanov, Iroda Mammadinova, Karashash Menlibayeva, Yeldar Kydyrmoldin, Ramazan Duisengali, Diana Kerimbayeva, Serik Akshulakov, Yerbol Makhambetov

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chingiz NurimanovDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Iroda MammadinovaDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Karashash MenlibayevaDepartment of Population Health Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Yeldar KydyrmoldinDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Ramazan DuisengaliDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Diana KerimbayevaDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Serik AkshulakovDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.
Yerbol MakhambetovDepartment of Vascular and Functional Neurosurgery, National Center of Neurosurgery, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carotid-cavernous fistulas (CCFs) are abnormal connections between the carotid artery and/or its branches and the cavernous sinus, potentially resulting in significant complications, including visual impairment and neurological deficits. Timely diagnosis and appropriate therapeutic intervention are critical to minimizing the risk of adverse outcomes. Over the years, endovascular techniques have become the preferred method for treating CCFs, offering high success rates with fewer complications. This study aims to study the clinical and radiological outcomes of patients with CCFs treated with endovascular approaches, and to identify key prognostic factors associated with treatment efficacy and symptomatic resolution. Methods: A retrospective analysis was conducted of patients diagnosed with carotid-cavernous fistulas (CCFs) and treated at the National Center for Neurosurgery in Astana, Kazakhstan, between 2008 and 2024. A total of 71 patients underwent endovascular embolization using either transarterial or transvenous techniques. According to the Barrow classification, type A CCF were observed in 62 patients (87.3%), type D in 7 patients (9.9%), and types B and C in 1 patient each (1.4%). Collected data included patient demographics, type of embolic materials utilized, number of procedures performed, treatment approach, and corresponding radiological and clinical outcomes. Results: Among the 71 patients included in the study, 80.3% achieved complete clinical resolution, 15.5% demonstrated partial improvement, and 4.2% experienced no clinical benefit. The mean age was 35.7 ± 12.9 years, with 71.8% males. Clinical outcomes were significantly associated with complete occlusion following the initial intervention ( Conclusion: Endovascular embolization is a safe and effective first-line treatment modality for CCFs. Both transarterial and transvenous approaches offer comparable rates of clinical success. Achieving complete occlusion is a critical determinant of favorable clinical outcomes and is associated with a reduced risk of treatment-related complications.

Indexed as

carotid-cavernous fistulasendovascular treatmentlong term resultstransarterial approachtransvenous approach

Identifiers

PMID40933047
PMCPMC12417146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.